Pembrolizumab in Treating Participants With Leukoplakia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab and EDP1503 in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Universal HIV Screening and Targeted HCV Screening in Emergency Department
- Status
- COMPLETED
- Phase
- NA
Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
- Status
- UNKNOWN
- Phase
- N/A
A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk
- Status
- WITHDRAWN
- Phase
- PHASE4
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
- Status
- COMPLETED
- Phase
- PHASE4
Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)
- Status
- TERMINATED
- Phase
- PHASE2
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)
- Status
- COMPLETED
- Phase
- PHASE1
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)
- Status
- COMPLETED
- Phase
- PHASE1
IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant
- Status
- UNKNOWN
- Phase
- PHASE2
Contraception Initiation Feasibility in the Pediatric ED
- Status
- COMPLETED
- Phase
- NA